ET-Traps Limited

Best Endothelin-1 Therapeutic Targeting Company 2020
"ET-traps has devised a novel approach targeting endothelin-1, which has significantly elevated levels in a host of different diseases. It seems amazing that by controlling the levels of this molecule, hundreds of millions of lives can be dramatically improved. Just by sequestering endothelin-1, a molecule that shows significantly elevated levels in people suffering from serious ailments like neurodegenerative and cardiovascular diseases as well as diabetes, the disease is controlled. We have completed the pre-clinical research in the diabetes disease space. We are now set to enter clinical trials. Further, this platform technology can be applied to treat various other diseases.” Email : Website: